285 related articles for article (PubMed ID: 20599895)
1. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
Huang FJ; You WK; Bonaldo P; Seyfried TN; Pasquale EB; Stallcup WB
Dev Biol; 2010 Aug; 344(2):1035-46. PubMed ID: 20599895
[TBL] [Abstract][Full Text] [Related]
2. The NG2 Proteoglycan in Pericyte Biology.
Stallcup WB
Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
[TBL] [Abstract][Full Text] [Related]
3. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
4. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
[TBL] [Abstract][Full Text] [Related]
5. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
[TBL] [Abstract][Full Text] [Related]
6. Collagen VI ablation retards brain tumor progression due to deficits in assembly of the vascular basal lamina.
You WK; Bonaldo P; Stallcup WB
Am J Pathol; 2012 Mar; 180(3):1145-1158. PubMed ID: 22200614
[TBL] [Abstract][Full Text] [Related]
7. NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.
Yotsumoto F; You WK; Cejudo-Martin P; Kucharova K; Sakimura K; Stallcup WB
Oncoimmunology; 2015 Apr; 4(4):e1001204. PubMed ID: 26137396
[TBL] [Abstract][Full Text] [Related]
8. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
Ozerdem U; Stallcup WB
Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
[TBL] [Abstract][Full Text] [Related]
9. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
10. Early contribution of pericytes to angiogenic sprouting and tube formation.
Ozerdem U; Stallcup WB
Angiogenesis; 2003; 6(3):241-9. PubMed ID: 15041800
[TBL] [Abstract][Full Text] [Related]
11. Proliferating NG2-Cell-Dependent Angiogenesis and Scar Formation Alter Axon Growth and Functional Recovery After Spinal Cord Injury in Mice.
Hesp ZC; Yoseph RY; Suzuki R; Jukkola P; Wilson C; Nishiyama A; McTigue DM
J Neurosci; 2018 Feb; 38(6):1366-1382. PubMed ID: 29279310
[TBL] [Abstract][Full Text] [Related]
12. NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations.
Stallcup WB
Cancers (Basel); 2017 Mar; 9(4):. PubMed ID: 28362324
[TBL] [Abstract][Full Text] [Related]
13. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.
Gee MS; Procopio WN; Makonnen S; Feldman MD; Yeilding NM; Lee WM
Am J Pathol; 2003 Jan; 162(1):183-93. PubMed ID: 12507901
[TBL] [Abstract][Full Text] [Related]
14. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
15. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
[TBL] [Abstract][Full Text] [Related]
16. Pericytes promote selective vessel regression to regulate vascular patterning.
Simonavicius N; Ashenden M; van Weverwijk A; Lax S; Huso DL; Buckley CD; Huijbers IJ; Yarwood H; Isacke CM
Blood; 2012 Aug; 120(7):1516-27. PubMed ID: 22740442
[TBL] [Abstract][Full Text] [Related]
17. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
18. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
19. Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis.
Errede M; Mangieri D; Longo G; Girolamo F; de Trizio I; Vimercati A; Serio G; Frei K; Perris R; Virgintino D
Fluids Barriers CNS; 2018 Oct; 15(1):28. PubMed ID: 30290761
[TBL] [Abstract][Full Text] [Related]
20. Pericyte Progenitor Coupling to the Emerging Endothelium During Vasculogenesis via Connexin 43.
Payne LB; Tewari BP; Dunkenberger L; Bond S; Savelli A; Darden J; Zhao H; Willi C; Kanodia R; Gude R; Powell MD; Oestreich KJ; Sontheimer H; Dal-Pra S; Chappell JC
Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):e96-e114. PubMed ID: 35139658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
